Targeting Multiple Pro-apoptotic Signaling Pathways with Curcumin in Prostate Cancer Cells
Overview
Authors
Affiliations
Curcumin, an extract from the turmeric rhizome (Curcuma longa), is known to exhibit anti-inflammatory, antioxidant, chemopreventive and antitumoral activities against aggressive and recurrent cancers. Accumulative data indicate that curcumin may induce cancer cell death. However, the detailed mechanism underlying its pro-apoptotic and anti-cancer effects remains to be elucidated. In the present study, we examined the signaling pathways triggered by curcumin, specifically, the exact molecular mechanisms of curcumin-induced apoptosis in highly metastatic human prostate cancer cells. The effect of curcumin was evaluated using for the first time in prostate cancer, a gel-free shotgun quantitative proteomic analysis coupled with Tandem Mass Tag isobaric labeling-based-signaling networks. Results were confirmed at the gene expression level by qRT-PCR and at the protein expression level by western blot and flow cytometry. Our findings revealed that curcumin induced an Endoplasmic Reticulum stress-mediated apoptosis in PC3. The mechanisms by which curcumin promoted cell death in these cells were associated with cell cycle arrest, increased reactive oxygen species, autophagy and the Unfolded Protein Response. Furthermore, the upregulation of ER stress was measured using key indicators of ER stress: Glucose-Regulated Protein 78, Inositol-Requiring Enzyme 1 alpha, Protein Disulfide isomerase and Calreticulin. Chronic ER stress induction was concomitant with the upregulation of pro-apoptotic markers (caspases 3,9,12) and Poly (ADP-ribose) polymerase. The downregulated proteins include anti-apoptotic and anti-tumor markers, supporting their curcumin-induced pro-apoptotic role in prostate cancer cells. Taken together, these data suggest that curcumin may serve as a promising anticancer agent by inducing a chronic ER stress mediated cell death and activation of cell cycle arrest, UPR, autophagy and oxidative stress responses.
Modulating the p53-MDM2 pathway: the therapeutic potential of natural compounds in cancer treatment.
Ramli I, Cheriet T, Posadino A, Giordo R, Fenu G, Chukwuemeka Nwachukwu K EXCLI J. 2025; 23:1397-1439.
PMID: 39764218 PMC: 11701300. DOI: 10.17179/excli2024-7791.
Effects of curcumin and ursolic acid in prostate cancer: A systematic review.
Besasie B, Saha A, DiGiovanni J, Liss M Urologia. 2023; 91(1):90-106.
PMID: 37776274 PMC: 10976464. DOI: 10.1177/03915603231202304.
Dual RNase activity of IRE1 as a target for anticancer therapies.
Bartoszewska S, Slawski J, Collawn J, Bartoszewski R J Cell Commun Signal. 2023; 17(4):1145-1161.
PMID: 37721642 PMC: 10713974. DOI: 10.1007/s12079-023-00784-5.
Oncogenic Proteomics Approaches for Translational Research and HIV-Associated Malignancy Mechanisms.
Alvarez-Rivera E, Ortiz-Hernandez E, Lugo E, Lozada-Reyes L, Boukli N Proteomes. 2023; 11(3).
PMID: 37489388 PMC: 10366845. DOI: 10.3390/proteomes11030022.
Saetang J, Sukkapat P, Mittal A, Julamanee J, Khopanlert W, Maneechai K Biomedicines. 2023; 11(6).
PMID: 37371778 PMC: 10296375. DOI: 10.3390/biomedicines11061683.